Abstract:CD133 is a useful putative marker of cancer stem cells (CSCs) in human laryngeal tumors. Numerous studies have demonstrated that CD133(+) CSCs possess higher clonogenicity, invasiveness and tumorigenesis compared with CD133(-) cells. Recently, interest in the Warburg effect in the microenvironment of CSCs has escalated. The Warburg effect dictates that cancer cells rely on glycolysis rather than oxidative phosphorylation under aerobic conditions. In numerous cancer cells, glucose is used mainly for the glycolytic pathway. Stem cells express high levels of glycolytic enzymes and rely mostly on glycolysis to meet their energy demands. Glucose is transported through cell membranes by glucose transporters (Glut). Studies of Glut-1 expression in CSCs are limited. In the present study, we investigated the proliferation of CD133(+) Hep-2 cells and whether Glut-1 is expressed in laryngeal carcinoma CD133(+) Hep-2 cells. Real-time reverse transcription-polymerase chain reaction (RT-PCR) demonstrated that the size of the CD133 product was 213 bp. Dissociation curve analysis demonstrated only the expected peaks at 82.1 degrees C for CD133. The mean Ct of CD133 expression was 10.98. Prior to isolation, the CD133(+) fraction was 1.2% by fluorescence-activated cell sorting (FACS) analysis. Following isolation, the CD133(+) fraction was increased to 76.1%. Successive tests also demonstrated that cells grew well following isolation. The proliferation of CD133(+) and CD133(-) cells was not different during the first 3 days (P>0.05). From day 4, the proliferation capacity of CD133(+) cells in vitro was higher than that of CD133(-) cells (P<0.05). The mean Ct of Glut-1 mRNA expression was 1.78 for CD133(+) cells and 1.00 for CD133(-) cells (P<0.05). The mean Glut-1 protein values in CD133(+) and CD133(-) Hep-2 cells relative to -tubulin were 0.48 +/- 0.02 and 0.21 +/- 0.03 (g/l), respectively (P<0.05). In conclusion, CD133(+) cells demonstrated higher proliferation. Glut-1 mRNA and protein levels were higher in CD133(+) than in CD133(-) cells. Our results suggest that Glut-1 is important in the energy supply of laryngeal CD133(+) Hep-2 cells and Glut-1 may represent a potential therapeutic target for the inhibition of the proliferation of laryngeal CSCs.

CD133 Positive Hepatocellular Carcinoma Cells Possess High Capacity for Tumorigenicity.

Cancer Stem/Progenitor Cells Are Highly Enriched In Cd133(+)Cd44(+) Population In Hepatocellular Carcinoma

G Protein-Coupled Receptor 87 (Gpr87) Promotes The Growth And Metastasis Of Cd133(+) Cancer Stem-Like Cells In Hepatocellular Carcinoma

Cancer stem/progenitor cells are highly enriched in CD133<sup>+</sup>CD44<sup>+</sup> population in hepatocellular carcinoma

[Investigation of CD133 As Putative Marker of Tumor-Initiating Cell in Laryngeal Carcinoma].

Glucose transporter-1 expression in CD133+ laryngeal carcinoma Hep-2 cells.

CD133 and epithelial cell adhesion molecule expressions in the cholangiocarcinoma component are prognostic factors for combined hepatocellular cholangiocarcinoma

Stem-Like Cells In Hepatitis B Virus-Associated Cirrhotic Livers And Adjacent Tissue To Hepatocellular Carcinomas Possess The Capacity Of Tumorigenicity

[Isolation and in Vivo Tumorigenicity Assay of CD133+ Side Population Cells from Laryngeal Cancer Cell Line].

Quantitative Analyses of CD133 Expression Facilitate Researches on Tumor Stem Cells.

CXCL3 contributes to CD133 + CSCs maintenance and forms a positive feedback regulation loop with CD133 in HCC via Erk1/2 phosphorylation

[Isolation and in Vitro Characterization of CD133(+) Side Population Cells from Laryngeal Cancer Cell Line].

Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.

The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.

CD133 as a marker for cancer stem cells: progresses and concerns.

Evidence of CD90+CXCR4+ Cells As Circulating Tumor Stem Cells in Hepatocellular Carcinoma

Cooperation of Side Population Cells with CD133 to Enrich Cancer Stem Cells in a Laryngeal Cancer Cell Line

A new risk model comprising genes highly correlated with CD133 identifies different tumor-immune microenvironment subtypes impacting prognosis in hepatocellular carcinoma

The Power and the Promise of Liver Cancer Stem Cell Markers.

The critical role of CD133 + CD44 +/high tumor cells in hematogenous metastasis of liver cancers

Constitutive Expression Of Wnt/Beta-Catenin Target Genes Promotes Proliferation And Invasion Of Liver Cancer Stem Cells